|
CCNB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.66539998353232E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.90640000000176E-05 |
| Normal-vs-Stage2 |
7.521600E-03 |
| Normal-vs-Stage3 |
1.613300E-04 |
| Normal-vs-Stage4 |
1.91478000000078E-05 |
| Stage1-vs-Stage2 |
7.373000E-01 |
| Stage1-vs-Stage3 |
5.274300E-02 |
| Stage1-vs-Stage4 |
9.163600E-04 |
| Stage2-vs-Stage3 |
1.703780E-01 |
| Stage2-vs-Stage4 |
2.742300E-03 |
| Stage3-vs-Stage4 |
3.697600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.99580005247435E-09 |
| Normal-vs-AfricanAmerican |
8.302300E-02 |
| Normal-vs-Asian |
2.868200E-01 |
| Caucasian-vs-AfricanAmerican |
5.827700E-02 |
| Caucasian-vs-Asian |
5.949000E-01 |
| AfricanAmerican-vs-Asian |
4.174800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59149999845454E-08 |
| Normal-vs-Female |
3.94049999999924E-05 |
| Male-vs-Female |
5.610300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.187630E-02 |
| Normal-vs-Age(41-60Yrs) |
7.54000000000588E-05 |
| Normal-vs-Age(61-80Yrs) |
7.05420000191026E-08 |
| Normal-vs-Age(81-100Yrs) |
1.323020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.129900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.015200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.908500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.623780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.899200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.046200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.890200E-01 |
| Normal-vs-Grade 2 |
4.06830000000413E-05 |
| Normal-vs-Grade 3 |
2.7794000000414E-06 |
| Normal-vs-Grade 4 |
3.89020000000073E-05 |
| Grade 1-vs-Grade 2 |
1.742470E-03 |
| Grade 1-vs-Grade 3 |
4.04889999999769E-05 |
| Grade 1-vs-Grade 4 |
6.21929999999882E-05 |
| Grade 2-vs-Grade 3 |
2.454400E-02 |
| Grade 2-vs-Grade 4 |
8.445200E-04 |
| Grade 3-vs-Grade 4 |
8.875200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.976100E-02 |
| Normal-vs-ccB subtype |
1.99220000052236E-07 |
| ccA subtype-vs-ccB subtype |
1.59963999999402E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16269999997465E-06 |
| Normal-vs-N1 |
4.001300E-03 |
| N0-vs-N1 |
2.342000E-02 |
|
|
